Kaijiang Xia

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury

Kaijiang Xia, Fang Zhu, Chengkui Yang et al. · Frontiers in Cell and Developmental Biology · 2020 · 45 citations · Full text

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity

Zhanhui Li, Xu Wang, Lin Yu et al. · European Journal of Medicinal Chemistry · 2020 · 24 citations · Full text

Cxcr4 Antagonists, Polymer-drug Conjugate, Medicine +6

Ring closure strategy leads to potent RIPK3 inhibitors

S. C. Wu, Xu Chen, Kaijiang Xia et al. · European Journal of Medicinal Chemistry · 2021 · 21 citations · Full text

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +6

An asymmetric structure of bacterial TrpRS supports the half-of-the-sites catalytic mechanism and facilitates antimicrobial screening

Manli Xiang, Kaijiang Xia, Bingyi Chen et al. · Nucleic Acids Research · 2023 · 11 citations · Full text